eUltra 10k test for adults using the Biofreedom Ultra device
This trial studies a medical device called Biofreedom Ultra, using the study’s official instructions for safe use. If you’re an adult, you can join after giving consent, unless specific legal or pregnancy-related protections apply.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must sign a consent form to join the study
- You must meet the device’s current instructions for safe use (as listed in the study paperwork)
- You must not fall under exclusion rules related to pregnancy or breastfeeding (per study rules)
- You must not be under legal protections such as guardianship or curatorship, or be deprived of liberty
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication (UI087) in healthy volunteers to see how safe it is and how the body processes it, compared to taking three separate medicines together. It's an early-phase trial that may help future patients with a similar treatment option.
This study tests an investigational medical device (the UltraTrac) worn on the skin while children undergo a routine heart catheterization. The device aims to improve monitoring during the procedure and may help guide care more safely.
This study tests a device called UltraTrac that checks your heart and lung health without needles or invasive procedures. It may help doctors better monitor conditions like heart failure or asthma in the future.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This study tests how well a new breast scanning device works in people who volunteer. You may be eligible if you can safely tolerate the scan and fit your breast into the device.
This study tests a new non-invasive device called UltraTrac that measures how well the heart pumps blood in people with congenital heart disease. It will be used during standard heart procedures or intensive care stays to see if it works as well as current methods.
Hear when a new Post Market Clinical Follow up (PMCF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.